Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19114683 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)
Conditions: Neoplasm Metastasis;   Colorectal Cancer
Interventions: Biological: Cetuximab;   Drug: Oxaliplatin

Indicates status has not been verified in more than two years